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The safety of oats for people with celiac disease remains unresolved. While oats have
attractive nutritional properties that can improve the quality and palatability of the
restrictive, low fiber gluten-free diet, rigorous feeding studies to address their safety in
celiac disease are needed. Assessing the oat prolamin proteins (avenins) in isolation and
controlling for gluten contamination and other oat components such as fiber that can
cause non-specific effects and symptoms is crucial. Further, the avenin should contain
all reported immunogenic T cell epitopes, and be deliverable at a dose that enables
biological responses to be correlated with clinical effects. To date, isolation of a purified
food-grade avenin in sufficient quantities for feeding studies has not been feasible. Here,
we report a new gluten isolation technique that enabled 2 kg of avenin to be extracted
from 400 kg of wheat-free oats under rigorous gluten-free and food grade conditions.
The extract consisted of 85% protein of which 96% of the protein was avenin. The
concentration of starch (1.8% dry weight), β-glucan (0.2% dry weight), and free sugars
(1.8% dry weight) were all low in the final avenin preparation. Other sugars including
oligosaccharides, small fructans, and other complex sugars were also low at 2.8% dry
weight. Liquid chromatography tandem mass spectrometry (LC-MS/MS) analysis of the
proteins in these preparations showed they consisted only of oat proteins and were
uncontaminated by gluten containing cereals including wheat, barley or rye. Proteomic
analysis of the avenin enriched samples detected more avenin subtypes and fewer other
proteins compared to samples obtained using other extraction procedures. The identified
proteins represented five main groups, four containing known immune-stimulatory avenin
peptides. All five groups were identified in the 50% (v/v) ethanol extract however the
group harboring the epitope DQ2.5-ave-1b was less represented. The avenin-enriched
protein fractions were quantitatively collected by reversed phase HPLC and analyzed by
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MALDI-TOF mass spectrometry. Three reverse phase HPLC peaks, representing ∼40%
of the protein content, were enriched in proteins containing DQ2.5-ave-1a epitope. The
resultant high quality avenin will facilitate controlled and definitive feeding studies to
establish the safety of oat consumption by people with celiac disease.
Keywords: oats, avenin, gluten-free diet, LC-MS, MALDI-TOF, celiac disease

INTRODUCTION

rye belong to the same Poaceae family but oats are sub-classified
into the Aveneae tribe, while the other cereals belong to the
Triticeae tribe. This phylogenetic relationship is exemplified by
the homology between oat avenin sequences with those in αand γ-gliadins of wheat, the B-hordeins of barley and the γsecalins of rye. Notably, there is no homology with the 33
mer peptide from wheat α-gliadin that encompasses several
highly immunostimulatory T cell epitopes in CD. An important
distinction is that within the Triticeae tribe, gluten protein makes
up 75–80% of the protein in wheat, 45–50% in rye, and 50–55% in
barley, but in the Aveneae tribe the equivalent prolamin protein
(avenin) makes up only 10–15% of the protein i.e., 1% of the
flour (16). This has particular relevance for feeding studies in
CD. To illustrate, the consumption of 3–7 g wheat gluten daily
induces typical clinical effects in most CD patients after 2 weeks
(17), however the equivalent avenin prolamin dose would require
the consumption of ∼300–700 g oats per day. As a standard
serving size is ∼30–40 g, this is impractical and makes oat feeding
studies aiming to reliably induce and assess biological effects
near impossible.
A strict GFD is essential to ensure mucosal healing in CD
and a failure to heal is correlated with higher morbidity and
mortality (18, 19). This is an onerous, costly and restrictive
treatment and its ability to induce CD remission is compromised
by poor dietary adherence (20). The GFD is generally lower in
dietary fiber and frequently higher in simple carbohydrates and
fat (21). The introduction of oats to the GFD increases the range
of foods that can be consumed, provides an excellent source of
fiber and increases GFD palatability and adherence. Soluble fiber
and β-glucan found in oats have been associated with a range
of health benefits including reduced serum cholesterol (22, 23).
Oats may support the 8–10% of CD patients who also suffer
Type 1 diabetes mellitus by lowering post-prandial glycaemia and
improving glycaemic control. Long-term oat consumption in CD
may also improve quality of life (24).
In the face of these extremely positive nutritional attributes
for oats in people with CD yet with the uncertain issue of
their safety, there is a strong medical need to resolve this
issue. It has become clear from trials in a separate clinical
entity, non-celiac wheat sensitivity (NCWS), that properly
controlled feeding studies to assess the clinical effects of gluten
need to feed purified gluten, and not whole wheat (25).
Wheat contains a broad mix of proteins [including gliadins,
glutenins, amylase trypsin inhibitors (ATIs), and globulins] and
carbohydrates. Recent controlled feeding studies indicate the
fermentable carbohydrate component, fructan, is the driver of
adverse gastrointestinal symptomatology in many people with
NCWS (26). While oats, unlike wheat, is considered low in
fermentable carbohydrates (27), it is high in fiber which could

Establishing a safe gluten-free diet (GFD) for people with celiac
disease (CD) is important for the health of the 1.4% of affected
sufferers globally (1). CD is a chronic immune illness with
features closely related to autoimmunity, and its pathogenesis
is strongly linked to CD4+ T cells that are activated by dietary
gluten peptides (2). Since the 1950s, after gluten was identified as
the causative antigenic trigger, its sole treatment has been strict
and lifelong gluten exclusion by removing wheat, barley, and rye.
In this clinical context, the term gluten encompasses all of the
pathogenic prolamin proteins from wheat (gliadin and glutenin),
barley (hordein) and rye (secalin) that are immunotoxic in CD.
Oats contain a gluten-like prolamin protein called avenin
and early food challenge studies indicated they can cause
clinical relapse in some people with CD (3). More recent
oat feeding studies that control for the confounding effect
of wheat and barley contamination have indicated that pure
oats are safe in CD although methodological limitations of
these studies have been identified (4). A few clinical studies
have shown mucosal inflammation (5), raised intra-epithelial
lymphocytes (6, 7), or villous atrophy (8) induced by oats,
suggestive of an adverse CD effect. A variety of in vitro
studies have shown oat fractions can induce pro-inflammatory
immune effects (9–11). Importantly, key avenin peptides that
stimulate the pathogenic gluten-specific T cells in CD patients
in vivo have been defined (12, 13). These peptides contain the
immunodominant T cell epitopes DQ2.5-ave-1a (PYPEQEEPF),
DQ2.5-ave-1b (PYPEQEQPF), DQ2.5-ave-1c (PYPEQEQPI),
and DQ2.5-ave-2 (PYPEQQPF) with close sequence homology to
barley T cell epitopes immunotoxic in CD such as DQ2.5-hor-3
(PIPEQPQPY) (14). The collective uncertainty of these findings
regarding the true clinical safety of oats in CD has translated into
different feeding recommendations; while Australia and New
Zealand mandate the exclusion of oats from the GFD, most
countries do not.
Oats are the sixth most significant cereal crop in the world,
with production exceeding 24 million tons annually, and Avena
sativa is the most important crop (15). Oats, wheat, barley and
Abbreviations: AACC, American Association of Cereal Chemists; ATIs, αamylase/trypsin inhibitors; CD, coeliac disease; cRAP, common Repository
of Adventitious Proteins; DTT, dithiothreitol; FDA, US Food and Drug
Administration; GFD, gluten-free diet; HRP, horseradish peroxidase; IPA, propan2-ol; IPA/DTT, 50% (v/v) IPA, 1% (w/v) DTT; LC-MS/MS, liquid chromatography
tandem mass spectrometry; LOD, limit of detection; MALDI-TOF-MS, matrixassisted laser desorption ionization time-of-flight mass spectrometry; NCWS,
non-celiac wheat sensitivity; RP-HPLC, reverse phase high pressure liquid
chromatography; Urea/DTT, 8 M urea, 1% (w/v) DTT, 20 mM triethylamine-HCl
(pH 6).
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trigger adverse gastrointestinal symptoms such as bloating or
abdominal discomfort independent of its avenin content. With
remarkable foresight, researchers in 1958 reported the challenge
of getting children with CD to consume enough oats to establish
clinical safety, and identified the need to extract oat protein i.e.,
avenin to address this challenge (28). At the time, the author
lamented, “The possibility of using oat protein itself was explored
but although several methods of preparation were attempted,
considerable difficulties were encountered.” Thus, there exists
a need for purified and uncontaminated food-grade avenin in
sufficient quantities for CD feeding studies. We present here
a simple method capable of isolating purified, avenin-enriched
protein. We demonstrate the avenin is of food-grade standard,
uncontaminated by agricultural chemicals and heavy metals, and
suitable for human feeding trials.

was sealed, a 100 g flour sample was taken from each bag and
screened for accidental contamination with herbicides, pesticides
and common aflatoxins (Supplementary Table S1) by Agrifood
Technology (Werribee, Australia). Purified avenin was also
screened for heavy metal contamination. The flour was extracted
using food grade procedures and ethanol in a lab decontaminated
to remove traces of wheat flour (Manildra Group, Nowra). All
containers used for solvent storage and extraction were Food and
Drug Approved and bisphenol A-free (Bunnings, Australia).

Effect of Solvent Polarity on Small Scale
Avenin Precipitation
Oat flour (500 g) was extracted twice in 50% (v/v) ethanol
(750 mL) and the extracts pooled. Duplicate 10 mL aliquots
of the pooled 50% (v/v) ethanol extract containing 5.2 mg
protein/mL was subject to varied total ethanol concentration
by diluting the 50% (v/v) ethanol extract with either water,
to achieve a final ethanol concentrations of 10–41% (v/v), or
with ethanol to achieve final ethanol concentrations of 66–90%
(v/v) (Figure 1A). In addition the 50% (v/v) ethanol extract
was also chilled at 4◦ C and centrifuged as below (Figure 1A).
Ethanol extracts were centrifuged at 3000 × g for 10 min at
room temperature and pellets were dissolved in 8 M urea, 1%
(w/v) dithiotreitol (DTT), 20 mM triethylamine-HCl (pH 6)
(Urea/DTT) during overnight incubation at room temperature.
The protein content of the resultant solutions was measured by
Bradford, and 20 and 2 µg protein aliquots were subjected to
Urea-SDS-PAGE and western blot respectively (Figures 1B,C).

METHODS
Protein Content Determination
Protein content was determined by the method of Bradford (29).

Proximate Composition Analysis
All proximate analyses were completed by a National Association
of Testing Authorities accredited food testing facility Agrifood
Technology (Werribee, Australia). In brief, protein content was
determined using the Kjeldahl method [American Association
of Cereal Chemists (AACC) Methods 70-20A and 70-70];
starch and total free sugars (fructose, glucose, lactose, maltose,
and sucrose) by in-house developed liquid chromatography—
mass spectrometry (LC-MS); β-glucan using enzymatic method
after hydrolysis by β-glucosidase (AOAC International Official
Method 995.16 and AACC Method 32-23); and water soluble
carbohydrates by water extraction and the anthrone method
(AFIA 1.11R).

Chill Precipitation of a Range of Gluten
Proteins
Gluten proteins were isolated from wheat, barley and oat flour
by extracting 5 g flour in 15 mL of 50% (v/v) ethanol, vortexing
regularly over 1 h, and centrifuging at 3,000x g for 1 h. The
50% ethanol (v/v) supernatants were chilled at 4◦ C overnight,
centrifuged as above and the pellets redissolved in Urea/DTT
(wheat 10 mL, barley 10 mL, and oats 1 mL). The prolamin
content of the chill precipitates were compared to duplicate
extracts of 50 mg (wheat, barley) or 100 mg oats in 1 mL of 50%
(v/v) propan-2-ol (IPA), 1% (w/v) DTT (IPA/DTT) which was
extracted by violent reciprocal shaking in a Savant bead beater
at 30 movements s−1 for 1 min and centrifuged at 13,000x g for
5 min. The protein content in the IPA/DTT supernatants and the
chill-precipitated pellets were determined and either 20 or 2 µg
protein were loaded on each lane of a protein gel and western
blot, respectively (Figures 2A,B).

Urea-SDS-PAGE and Western Blot Analysis
One dimensional urea-sodium dodecyl sulfate polyacrylamide
protein gels and Western blots were run as previously described
(30). The Sigma-anti-gliadin-horseradish peroxidase (HRP)
antibody used here, has been shown to be a general anti-gluten
antibody, detecting all gluten protein types present in wheat,
barley, rye, and oats (31).

Oat Cultivation and Purity
Two crops of oats (cv. Wandering, 200 kg) were grown in
Williams, in the south-east of Western Australia, using dedicated
wheat-free machinery and cropland, and harvested in September
2016 and December 2017. The oats were transported to
Melbourne in sealed “bulka” bags and processed in two batches
of 200 kg. Prior to grinding of each batch, sequential lots of
100 g of oats was spread thinly on a tray and examined for
other grains. No wheat, barley or ryegrass were detected in
any samples. No other material was detected, confirming the
purity of the oats. The oat grain was ground to pass a 40
hole/in screen, in a dedicated gluten-free hammer mill kindly
supplied by Wards Mackenzie (Altona, Australia). The flour was
captured in two batches of eight 25 kg bags. Before each bag

Frontiers in Nutrition | www.frontiersin.org

Avenin Isolation From 500 g Oats
Oat flour (500 g) was shaken regularly over 2 min, 90 min, or for
one or 2 days in 750 mL of 50% (v/v) ethanol and then centrifuged
at 500 g for 5 min and the supernatant reserved. Pellets were
resuspended in 750 mL 50% (v/v) ethanol, re-centrifuged and
the process repeated. The yield of protein was determined in the
pooled supernatants (Figures S1A,B).
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FIGURE 1 | Effect of solvent concentration on avenin precipitation. Adding water or ethanol (EtOH) precipitated avenin, however water-induced precipitate could not
be conveniently pelleted. Chill precipitation isolated as much protein as could be isolated by solvent precipitation with a final concentration of 90% ethanol. (B,C)
Effect of ethanol concentration (83, 87, 90, or 50% chill precipitation) on avenin precipitation by (B) protein gel or (C) western blot with Sigma anti-gliadin, this
antibody has previously been shown to identify all major gluten proteins including avenin (30). Protein bands not corresponding to western bands are indicated on (B),
*. Prestained 10 kDa ladder (Benchmark, Invitrogen) is shown to the left of (B,C). The pre-stained standards were themselves calibrated against Benchmark unstained
standards which have accurately designated molecular weights.

Large Scale (Sequential) Oat Extraction

Eppendorf Centrifuge 5424. The supernatant was filtered using
a 0.45 µm filter. The protein extracts were separated using an
Agilent 1200 LC system (Agilent Technologies) using a modified
method (32). An aliquot (10 µl) of extract was injected into a
C18 reversed-phase Zorbax 300SB-C18 column (4.6 × 150 mm,
5 µm, 300 Å, Agilent Technologies) maintained at 60◦ C. The
eluents used were ultrapure water (solvent A) and acetonitrile
(solvent B), each containing 0.1% trifluoroacetic acid (TFA)
(HPLC grade, Sigma Aldrich). The separation was carried out
using a linear gradient from 33 to 80% solvent B over 65 min at a
flow rate of 1 mL/min.

Over the course of 9 days in January 2018 and May 2018, two lots
of 200 kg of oat flour were ground in a blender to a fine flour,
and extracted with 50% (v/v) ethanol as follows. First, 8 kg lots
of oat flour were soaked in 12 L of 50% (v/v) ethanol overnight
with occasional mixing at room temperature. Tap water was used
for all solutions except where noted. In the morning, the oat flour
suspension was stirred and decanted into successive 6 × 500 mL
buckets and centrifuged at 800 × g for 5 min at 20◦ C in a Sigma
6-16S centrifuge to give a firm pellet. The clear supernatants
were pooled in a 30 L bottle and chilled at 4◦ C for 1–2 days to
selectively precipitate the avenins. The bulk of the avenin settled
after 2 days storage at 4◦ C and was removed from the bottom of
the storage container by decanting the supernatant. The avenin
precipitate which remained in the supernatant was collected by
centrifugation at 5,000x g for 10 min at 4◦ C and formed a clear
honey-like pellet which, with the bulk of the avenin above, was
resuspended in a minimum volume of 10% (v/v) ethanol, made
with reagent grade 18 MΩ water, and stored at 4◦ C. Clumps
of precipitated avenin were dispersed with an overhead blender,
frozen, and freeze-dried in a dedicated gluten-free facility to yield
a white powder which was stored dry at −20◦ C until required. A
final yield of 0.9 and 1.2 kg of freeze dried avenin was recovered
from each 200 kg oat flour (Figures S2A–C).

Protein Profiling Using Matrix-Assisted
Laser Desorption Ionization Time-of-Flight
Mass Spectrometry (MALDI-TOF-MS)
Analysis
Mass spectra representing the protein composition of the
prolamin-enriched fraction were obtained from both flour and
the purified avenin, and the RP-HPLC fractions collected from
the purified avenin sample using MALDI-TOF-MS. Briefly,
60 mg flour sample or 10 mg purified avenin was extracted in
triplicate using 300 µL of 70% (v/v) ethanol with vortex mixing
for 30 min at room temperature. The protein extract (200 µL)
as well as the equivalent amount of eluent from each collected
RP-HPLC peak were lyophilized and resuspended in matrix
consisting of 40 mg of sinapinic acid (SA), 600 µL of acetonitrile,
360 µL of methanol and 80 µL of water. An aliquot (1 µL) of
this matrix was spotted on a 100 spot MALDI-TOF plate and an
additional 1 µL sample layer was applied. An Applied Biosystems
Voyager DE Pro MALDI-TOF mass spectrometer was operated
in linear high mass positive mode using 2050 V laser intensity, an

Reversed Phase High Pressure Liquid
Chromatography (RP-HPLC) Analysis
Purified, freeze dried avenin (10 mg) was re-solubilized
using 70% (v/v) ethanol and vortexed for 30 min (MO BIO
Laboratories, Inc. Vortex-Genie R 2). Samples were prepared
in triplicate and were centrifuged for 20 min at 15870x g in an
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FIGURE 2 | Chill induced precipitation is a general method for all gluten proteins. Gluten proteins were isolated from wheat, barley, and oats by chill precipitation (WCP,
BCP, OCP respectively, Chill pptd) and compared to gluten proteins freshly isolated by extraction of wheat, barley and oats in 50% EtOH, 1% DTT (W1, W2, B1, B2,
O1, and O2, respectively, 50% EtOH, 1% DTT) by SDS-PAGE (A; 20 µg per lane), or western blot (B; 2 µg protein per lane). Corresponding protein bands, calibrated
against pre-stained standards are numbered 1–28 in both images. The inset (C,D) shows an overdeveloped section of the western blot to highlight faint bands.

Protein Identification From the Enriched
Avenin and Oat Flour

acceleration voltage of 25 kV, grid at 93% and guide wire at 0.2
settings, with 700 ns delay time. A total of 1,000 laser shots were
averaged per spectra with three technical replicates analyzed. The
detection mass range was set between m/z 10,000–60,000.

Proteins were extracted in four replicates using the finely ground
oat cv Wandering flour and solvents suitable to obtain gluten
protein enriched extracts: A −50% (v/v) ethanol; B −55% (v/v)
IPA + 2% (w/v) DTT in water following the protocols of Colgrave
et al. (31). The purified avenin sample was resolubilized in
50% (v/v) ethanol. From these, 100 µL aliquots of extract were
applied to a 10 kDa molecular weight cut-off filter (Millipore,
Sydney, Australia), alkylated using iodoacetamide and digested
overnight using sequencing-grade trypsin (Promega, Madison,
USA) or chymotrypsin (Promega, Madison, USA) as described
in Fallahbaghery et al. (35). After digestion, samples were
centrifuged at 20,000x g for 15 min and the digested filtrates were
dried in a Speedvac (Thermo Fisher Scientific) and the obtained
peptides were stored at −20◦ C until analysis.
Prior to LC-MS analysis the peptides were resuspended in 100
µL of 1% (v/v) formic acid. An aliquot (4 µL) of the peptide digest
solutions were separated on an Eksigent NanoLC 415 system
(SCIEX, Redwood City, USA) using a trap-elute configuration
and 10 µL/min flow rate for trapping and 5 µL/min flow rate for
separation. A Protecol C18 120Å trapping column (3 µm particle
size, 10 mm × 300 µm, Trajan Scientific, Australia) and an

LC-MS/MS Analysis of the Collected RP
HPLC Peaks
Protein samples were digested by chymotrypsin and peptides
were extracted according to standard techniques (33). The
peptide samples were analyzed by LC-MS on an Agilent 1260
Infinity HPLC system coupled to an Agilent 1260 Chipcube
Nanospray interface on an Agilent 6540 mass spectrometer.
Peptides were loaded onto a ProtID-Chip-150 C18 column
(Agilent) and separated with a linear gradient of solvent A (2%
acetonitrile/97.9% water/0.1% formic acid v/v/v) and solvent B
(98% acetonitrile/1.9% water/0.1% formic acid v/v/v) from
2 to 98% solvent B over 18 min. Spectra were analyzed to
identify proteins of interest using in silico proteolytic digests
of Poales subset of UniProt-KB database (accessed 23/05/2019)
supplemented with an oat seed transcriptome dataset (34) and
appended with the common repository of adventitious proteins
(cRAP). The number of protein sequences in the database
was 861,955.
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identified in the western blot (Figure 1C, 1-6). Some nonavenin proteins were present in the protein gel (Figure 1B, ∗ ).
In addition the intensity of both protein and western bands
was a maximum in the chill precipitation from 50% ethanol
(Figures 1B,C). This indicated that chill precipitation produced
an avenin precipitate of high purity showing higher specificity
for avenins.
Chilling the water-induced precipitates at 4◦ C did not help the
suspensions to precipitate, possibly due to protein-lipid binding
causing the avenins to float. Defatting the oat flour with common
defatting solvents (i.e., butanol, ether, or hexane) was not possible
due to food safety concerns. For instance, n-hexane biodegrades
to form a neurotoxin that must be avoided to maintain food
grade standard. Successful and complete defatting of oat flour
with 100% ethanol has been reported (40). However, in this study
ethanol defatting did not allow protein precipitation at lower
centrifugal force, suggesting that the difficulty in pelleting the
water-induced precipitates was not due to lipid interaction.

Eksigent ChromXP C18 120Å analytical column (3 µm particle
size, 150 mm × 300 µm) was used with a linear gradient from 3
to 25% solvent B over 68 min. Mobile phases consisted of solvent
A [0.1% (v/v) formic acid/5% (v/v) dimethyl sulfoxide/94.9%
(v/v) water] and solvent B [0.1% (v/v) formic acid/5% (v/v)
dimethyl sulfoxide/84.9% (v/v) acetonitrile/10% (v/v) water], and
0.1% (v/v) formic acid/99.9% (v/v) water was used to load the
trap column. The eluate was directed into a TripleTOF 6600 MS
(SCIEX), operating in information dependent acquisition mode
over mass range m/z 100–2000. The Paragon algorithm of
ProteinPilot 5.0.2 Software (SCIEX) was used for protein
identification (36). The tandem mass spectrometry data were
searched against the in silico proteolytic digests of Poales subset
of UniProt database (accessed 23/05/2019) supplemented with
the oat seed transcriptome data (34) and appended with the
common Repository of Adventitious Proteins (cRAP) database.
The database search results were examined and identifications
were confirmed if they passed a 1% global false discovery rate
(FDR) threshold as determined by the built-in FDR tool within
ProteinPilot software (37). The resulting protein dataset was
analyzed to identify avenins using the representative prolamin
characteristics as described (38). Pfam domains, cysteine residues
and major known T cell epitopes (DQ2.5-ave-1a, 1b, 1c, and
2) were mapped to the identified protein sequences using
CLC Genomics Workbench v12 (Qiagen, Aarhus Denmark).
Protein sequences were aligned using ClustalW algorithm and
phylogenetic analysis was performed as reported elsewhere (39).

Chill Precipitation Is a General Method
Applicable to a Range of Gluten Proteins
Chill-induced precipitation was assessed for its utility as a
general method for isolating gluten proteins. Gluten proteins
were isolated from oats, barley and wheat in 50% (v/v) ethanol
extracts, followed by chill precipitation (Figures 2A,B, Chill
ppted, Oats Chill Precipitated (OCP), Barley Chill Precipitated
(BCP), Wheat Chill Precipitated (WCP), respectively), and
compared to gluten proteins isolated by duplicate extraction
of oats, barley and wheat in 50% (v/v) ethanol, 1% (w/v)
DTT (Figures 2A,B, 50% ethanol/DTT, O, B, W, respectively).
Previous studies have demonstrated that IPA/DTT is able to
efficiently extract the majority of gluten proteins (35). In each
case gluten proteins, numbered 1–28 in both images, and by
definition extracted by 50% (v/v) ethanol, 1% (w/v) DTT were
present in the corresponding 50% (v/v) ethanol chill-precipitated
fractions. This was observed for Coomassie stained protein
bands (Figure 2A) and gluten-specific proteins by western blot
(Figure 2B, highlighted in Figures 2C,D) confirming that chill
precipitation isolated the same range of gluten proteins that were
isolated from wheat, barley, and oats as extraction in 50% (v/v)
ethanol/1% (w/v) DTT, thus confirming the general nature of the
chill precipitation method.

RESULTS
Effect of Solvent Concentration on Avenin
Precipitation
Many gluten proteins can be dissolved in 50% (v/v) ethanol or
2-propanol and precipitated by dilution with either water or
alcohol. The polarity of the 50% (v/v) ethanol avenin extract
was varied by diluting the 50% ethanol extract with water to
achieve final concentrations of 10–41% ethanol (v/v), or with
ethanol to achieve final concentrations of 66–90% ethanol (v/v)
(Figure 1A). All additions (water or ethanol) to the 50% ethanol
extract produced a milky white precipitate; however only those
precipitates produced by increasing the ethanol addition could
be conveniently precipitated. The cloudy precipitate produced by
adding water was extremely difficult to spin down and resisted
precipitation at 5,000 g, beyond the capacity of the centrifuge
used for the large scale avenin preparation. Fortuitously, chilling
the 50% ethanol extract at 4◦ C for 10 min was noted to selectively
precipitate avenin, producing a milky white precipitate that could
be precipitated at either 500 g or 3000 g over 10 min (Figure S1B)
or that settled at 1 g overnight. The chill-induced precipitation
of avenin commenced below 15◦ C and could be reversed by
warming, resulting in a clear solution that could be reproduced
at least 10 times. The purity of the precipitates produced by
varying the ethanol concentration, or chilling, was investigated
by comparing proteins (Figure 1B) corresponding with avenin
bands on a western blot (Figure 1C). All of the major bands
present in the protein gel (Figure 1B, 1–6) correspond to avenins
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Avenin Yield and Purity
The maximum protein yield was produced by extracting 500 g oat
flour in 750 mL of 50% (v/v) ethanol over 1–2 days (Figure S1A).
The protein purity of the large scale avenin preparation was
firstly examined by resolving protein bands with detection using
a general protein stain (Coomassie Blue G250; Figure 3A). The
protein bands were then compared to avenin bands identified
by a general anti-gluten antibody on a Western blot (Figure 3B)
for large scale avenin preparations 1 and 2 (Prep1 and Prep2).
Using calibrated pre-stained standards on the blot and protein
gel, avenin bands on both the protein gel and western blot were
shown to be of the same molecular weight (Table 1). It is clear
that the protein bands (Figure 3A) were due to the dominant
avenin bands on the western blot (Figure 3B), except for one

6

October 2019 | Volume 6 | Article 162

Tanner et al.

Preparation and Characterization of Avenin-Enriched Oat Protein

FIGURE 3 | Purity of avenin isolation from 200 kg avenin preparations by SDS-PAGE protein gel (A) or western blot (B). Two hundred kilograms of oat flour was
successively purified to yield two lots of purified avenin (Prep 1) and (Prep 2) are shown calibrated against pre-stained 10 kDa ladder (PM). Avenin was dissolved in 8 M
urea, 1% DTT, 20 mM triethylamine (pH6), protein measured and 1, 2, 4, or 5 ug loaded per lane as shown. A single non-avenin protein band was present at 14.1 kDa
(Figure 2A, white broken rectangle) corresponding to 4.2% of total band intensity. This does not correspond to an avenin band in the western blot 2B, and was
probably due to α-amylase/trypsin inhibitors. The protein composition of the initial 50% (v/v) ethanol extract of preparation 1 and 2 are shown (A, 1 & 2).

maltose and sucrose, and are soluble and are thus included
in the WSC measurement, leaving 2.8% DW attributed to
other sugars, such as oligosaccharides, small fructans, and other
complex sugars.
Food grade purity was confirmed by nil detection of herbicides
and/or pesticides (Supplementary Table S1). No inadvertent
chemical contamination was detected in either of the oat crops.
Both oat crops were tested for the presence of aflatoxins
(Supplementary Table S1), and all were below the limit of
detection (LOD listed in Supplementary Table S1). The purified
avenin was also tested for heavy metal contamination. Mercury,
chromium and lead were all below the limit of detection. Copper
was reported to be 5.1 and aluminum 58 mg/kg. These are within
acceptable safety limits. The US Food and Drug Administration
(FDA) reports that 10–100 mg aluminum per day is acceptable
(41). The proposed feeding trial will involve a daily intake of
0.35 mg aluminum in a 6 g serve of avenin. The FDA does not
define a limit on copper safety but these levels and much higher
are common in other foods. The Food Standard Australia New
Zealand code does not specify levels for copper or aluminum.

TABLE 1 | Comparison of avenin molecular weights calculated from protein gel
and western blots.
Avenin band

Molecular weight
(blot) kDa ± SE

Molecular weight
(gel) kDa ± SE

1

32.6 ± 0.02

33.0 ± 0.02

2

31.5 ± 0.02

31.5 ± 0.03

3

28.1 ± 0.07

28.6 ± 0.02

4

27.3 ± 0.08

27.3 ± 0.02

5

25.3 ± 0.09

25.3 ± 0.04

Molecular weights were compared from the protein gel and western blot proteins bands
in Figures 3A,B and calibrated against prestained standards.

protein band at ∼14 kDa, which did not correspond to an
avenin band in the western blot (Figure 3A, marked by a broken
white rectangle). Note that the 9 kDa prestained marker did not
bind to the membrane and did not appear in the Western blot
(Figure 3B, PM). The protein purity was calculated from the
percentage of the protein load attributed to avenin bands in the
protein gel. The average purity of both preparations shown for
the four 2 µg lanes on the protein gel was 95.8 ± 0.01%.

Proximate Composition Analysis

Comparative Proteomic Analysis of the
Enriched Avenin and Oat Flour

The protein content was assessed by the Kjeldahl method
revealing 85.4% protein. The remainder of the preparation
consisted of low concentrations of starch, β-glucan, free sugars
and water soluble carbohydrates. The starch content was 1.8%
on a dry weight (DW) basis. The β-glucan content was 0.2%
DW, total free sugars were 1.8% DW and the total watersoluble carbohydrate (WSC) content was 4.6% DW. As starch
is insoluble, it does not contribute to the WSC content. The
total free sugars (at 1.8% DW) include fructose, glucose, lactose,

Previous studies have shown that gluten proteins can be
efficiently extracted from gluten using alcohol in the presence of
reducing agents. Such solvents are not applicable to production
of food grade extracts, but are suitable for biochemical analyses
that aim to identify the protein complement in grains, flours, and
food products.
Extraction using IPA/DTT showed the highest number of
proteins in the oat flour sample after LC-MS/MS analysis of
the trypsin digested sample, with 276 proteins identified at the
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superfamily member proteins were also detected, including ATIs
(9%), kernel structure-related vromindoline and grain-softness
proteins (4.9%) and LTPs (4.1%). The remaining 164 proteins
in the flour extract represented seed storage globulins and
proteins with various enzyme and metabolic functions. In the
large-scale purified avenin sample, 12% of detected proteins
represented avenins, showing a qualitative enrichment in avenin
proteins. Of the remaining proteins, 16.6% were ATIs, 7.4% were
vromindolines and grain softness proteins and 4.5% were LTPs.
The remaining 104 proteins showed a similar composition to
that of the flour extract. The chymotryptic peptides yielded 105
protein identifications in the flour sample and 77 proteins in
the purified avenin sample with 42 proteins commonly detected
between the flour and the purified avenin sample. Identified
avenin sequences represented 19% of the detected proteins in the
flour sample and 27% in the purified protein sample. Similar to
the trypsin digested extracts, ATIs, vromindolines and LTPs were
also detected, though at lower numbers than in trypsin digested
protein samples (Table 2).
Utilizing chymotrypsin for proteolytic digestion and
subsequent LC-MS analysis resulted in an increased number
of unique avenin protein identifications independent of the
extraction solution used in the analysis. In total, 18% of the
identified proteins in the IPA/DTT flour extract were avenins
and a similar number (19%) were identified from the 50%
ethanol extract of flour. Using trypsin the abundance of avenins
within the identified protein pool was significantly lower: 5%
for the IPA-DTT and 8% for the 50% ethanol extract (Table 2).
Of the trypsin digested avenin proteins 50% were also identified
from the chymotrypsin digests. Comparing the number of
theoretically detectable tryptic and chymotryptic peptides, a
higher number of detectable chymotryptic peptides can be seen
in most of the sequences (Supplementary Table S2, Figure S3).
This resulted in the detection of an additional 15 avenin proteins
in the IPA/DTT and a further 11 avenin sequences in the 50%
ethanol extracts when chymotrypsin was used.
Both the oat flour and the purified avenin samples were
screened for the presence of wheat and barley contamination
using published methods (31, 42) and no evidence was found.

TABLE 2 | Number of detected protein types at 95 and 99% confidence levels.
Protein type

Protein
confidence
IPA/DTTa

Solvent

b

Enzyme
Avenin
ATI

Flour

TR

Purified sample

50% (v/v) ethanol
c

CTR

TR

CTR

TR

CTR

99%

18

20

17

19

18

18

95%

20

25

18

20

21

20

99%

18

17

15

16

19

16

95%

24

17

19

16

29

17

Vromindoline
and GSP

99%

14

8

10

5

11

6

95%

15

9

11

5

13

7

LTP and nsLTP

99%

8

4

7

4

6

1

95%

11

5

9

4

8

3

Globulin-like
proteins

99%

32

24

12

8

4

1

95%

38

26

13

12

6

2

Enzymes and
metabolic
proteins

99%

186

33

97

25

59

19

288

54

152

48

103

28

397

136

223

105

180

77

Total number
of proteins
a 55%

95%

IPA + 2% DTT extraction buffer; b trypsin; c chymotrypsin.

99% protein confidence level and additional 121 proteins were
identified when the confidence level was lowered to 95%. It
should be noted that LC-MS/MS is a very sensitive technique
capable of detecting proteins that vary in abundance over four
orders of magnitude. Detection of a number of non-avenin
proteins does not imply reduced purity, but that the technique
employed was capable of identifying a range of co-extracted
proteins that were not obvious on the gel images (Figure 3).
This protein set included 20 avenin sequences, 18 of which
were identified with 99% confidence (Table 2). Additionally,
there were 25 ATIs, 11 lipid transfer proteins (LTPs) and 15
vromindolines and grain softness proteins identified. A further
38 proteins were identified with the cupin-1 domain that is
characteristic of globulins and germins expressed in seeds. The
remaining 288 proteins represented a range of enzymes and
metabolic proteins. The chymotrypsin digested IPA/DTT extract
revealed 136 proteins, of which 106 were detected with 99%
protein confidence level. Within this set, 25 avenins (20 with
99% confidence level), 17 ATIs, 5 LTPs, 9 vromindolines and 26
globulins and germins were identified (Table 2). Comparing the
trypsin and chymotrypsin digests yielded 10 avenins, 14 ATIs, 7
vromindolines and 4 LTPs that were commonly identified when
IPA/DTT extraction was used during the sample preparation.
To obtain comprehensive protein information of the aveninenriched protein fractions, 50% ethanol extracts of the oat
flour and purified avenin were digested using trypsin and
chymotrypsin separately, and analyzed. Within the tryptic digests
(Table 2), 223 proteins were identified in the flour sample and
180 proteins were identified in the resolubilized avenin sample.
Of these, 96 proteins were commonly detected between the
flour and the purified avenin extracts. Of the detected proteins
in the flour sample 8.1% were avenins, while other prolamin
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Protein Molecular Weight and
Hydrophobicity Distribution Within the
Avenin-Enriched Extract
Altogether 25 protein peaks were identified in the undigested
purified extract using MALDI-TOF MS with centroid mass
values ranging between 19.3 and 32.4 kDa (Figure 4). The
proteins were grouped into three distinct groups: three proteins
represented proteins below 22.4 kDa, eight proteins with centroid
mass values between 22.4 and 24.4 kDa and 13 proteins with a
centroid mass range of 25.8 and 32.4 kDa.
The purified protein sample was also separated based on
hydrophobicity using RP-HPLC (Figure 5). The obtained
chromatogram peaks were grouped into two retention time
ranges. The first group represented peaks between retention
time values of 27.0 and 31.3 min and accounted for ∼57%
of the total protein. In this subgroup peaks between 29.6
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FIGURE 4 | Representative MALDI-TOF MS spectra of the undigested purified protein dissolved in 70% ethanol. The left y-axis represents signal intensity in arbitrary
units, the right y-axis shows the maximum intensity value. The x-axis represents the mass-to-charge ratios (m/z). The m/z values detected from the 70% ethanol
resolubilized purified protein extract are highlighted above the peaks.

FIGURE 5 | Representative reversed phase HPLC chromatogram of the purified oat protein sample resolubilized in 70% ethanol. The x-axis represents the retention
time in min, y-axis shows the relative amount of protein fractions in mAU units. Collected RP peaks and the % peak areas are labeled from RP1 to RP18 and
highlighted in gray.

and 31.3 min represented the most abundant peaks. The
second subgroup that accounted for 43% of the total protein
content was composed of 13 peaks and retention time values
ranged between 37.6 and 46.0 min. Peaks with retention time
values of 41.1, 46.0, and 45.1 min were the most abundant.
Based on the obtained chromatogram there were 18 peaks
collected and the undigested samples were subjected to
protein profiling using MALDI-TOF MS. In parallel to
this analysis proteins present in the chymotrypsin-digested
RP-HPLC peaks were identified using LC-MS/MS after
chymotrypsin digestion.

Frontiers in Nutrition | www.frontiersin.org

The RP-HPLC peaks were also quantified by calculating
the mean Area (mAU ∗ s) values of the three replicates ×
three injections. The absolute amount of protein within each
peak was estimated based on the obtained protein content
using the Kjeldahl method as described in section Proximate
Composition Analysis. The quantitative results, including
retention time ranges, calculated mean values as absolute
amounts of protein/100 g purified protein are provided in
Table 3.
The RP-HPLC peaks RP3-RP7 comprised proteins with the
larger molecular mass range (above 26 kDa). Peaks RP1 and
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Supplementary Table S2). Group 1 included proteins with the
epitope DQ2.5-ave-1b, the majority of the group 2 sequences
contained DQ2.5-ave-1c, group 3, the largest group, was typified
by the presence of DQ2.5-ave-1a and group 4 was typified by the
presence of DQ2.5-ave-2. The sub-branch without T cell epitopes
(group 5) represents protein sequences mostly similar to high and
low molecular weight glutenin-like sequences. The results clearly
indicate that the 50% ethanol extraction method is suitable to
extract the major epitope containing avenin types. The resultant
purified protein contains all of the reported immunogenic avenin
peptides, and therefore should be suitable as a way to assess their
clinical toxicity in feeding studies.

TABLE 3 | Identified proteins and their calculated amounts of the collected 18
RP-HPLC peaks.
RP
peak #

Retention time
peak (min)

Collection time Mean g/100 g
range (min)
protein

Range g/100 g
protein

1

26.85

26.6 – 26.9

0.57

0.37–0.72

2

27.38

27.1 – 27.8

1.90

1.65–2.05

3

28.18

28.0 – 28.6

3.29

3.18–3.42

4

29.04

28.7 – 29.1

2.72

2.39–3.04

5

29.54

29.2 – 30.0

17.05

16.64–17.55

6

30.47

30.1 – 30.6

13.13

12.52–13.55

7

30.93

30.7 – 31.0

6.57

6.20–6.89

8

31.15

31.0 – 31.7

10.69

10.10–11.20

9

37.42

37.2 – 37.7

0.99

0.73–1.59

10

38.48

38.2 – 38.6

0.63

0.33–0.85

11

39.72

39.3 – 40.4

1.58

1.40–1.83

12

40.95

40.4 – 41.6

9.29

8.65–9.74

13

41.69

41.9 – 42.3

2.54

1.10–1.28

14

42.77

42.3 – 43.2

5.16

4.50–4.86

15

44.16

43.8 – 44.4

2.99

2.66–3.38

16

44.50

44.4 – 45.3

7.05

6.65–7.53

17

45.94

45.4 – 45.9

4.74

4.56–4.96

18

46.20

46.0 – 46.4

9.11

8.67–9.56

DISCUSSION
Determining if oats should be excluded or included in the GFD
is an important issue with medical and societal implications.
Dedicated, controlled feeding studies are needed to definitively
resolve this issue. Here, we demonstrate an approach that enables
the production of a highly purified oat avenin preparation,
containing all the known immunogenic avenin T cell epitopes,
which contains minimal levels of other carbohydrates or proteins
which could otherwise confound the interpretation of the feeding
trial. This avenin preparation will facilitate immune and feeding
studies to test the suitability of oats in CD. Studies can now
be undertaken to assess the immunogenicity of this protein
using patient-derived gluten-specific T cells, and employ feeding
studies in patients with CD to determine its biological effects.
Despite the many nutritional benefits of oats, contradictory
clinical feeding studies, and lack of a clear scientific rationale for
dietary guidelines have led to differing views on the safety of oats
consumption in CD. A systematic review on studies of oat safety
in CD (4) identified several limitations including (i) small sample
sizes: uncommon patients with oats sensitivity may not have been
included; (ii) assessment of GFD adherence: often not reported;
(iii) adverse symptoms: cannot determine if they are related to
oats avenin or the fiber load of oats itself; and (vi) oat cultivars:
usually not reported. Furthermore, study withdrawals which
were often due to adverse gastrointestinal symptoms and/or the
inability to maintain the oats diet, may have underestimated the
adverse impact of oats intake, and recruitment bias, may lead
to oats-sensitive patients avoiding participating in oats feeding
studies. The authors concluded: “Our confidence is limited by
the low quality and limited geographic distribution of the data”
and “Rigorous double-blind, placebo-controlled, randomized
controlled trials, using commonly available oats sourced from
different regions, are needed.” (4).
An important consideration is that testing for cereal
contamination over the last two decades has highlighted a high
frequency of commercial oats brands contaminated by wheat,
barley and/or rye prolamin in amounts toxic to CD patients (43–
45). Contamination can occur since wheat, barley, and oats are
grown in the same areas and often harvested and transported
with the same machinery. The presence of a single grain of wheat
in 200 g of oats can result in the wheat gluten level of >100 ppm;
well above the 20 ppm level set in most legislations as the upper

RP8 were comprised of proteins spanning the entire mass range
while peaks RP9-RP12 mainly included proteins with smaller
molecular mass values (below 22.5 kDa). Peaks RP15-RP18
comprised proteins between 22.5 and 24 kDa and above 26 kDa.
The number of representative avenin protein types per peak is
shown in Table 4. Proteins present in the 18 peaks consisted of
avenins and gliadin-like avenins, however peptides characteristic
of ATIs were also confidently detected in peak RP2 (Table 4). RPHPLC analysis indicated that the proteins that eluted between
26.9 and 31.2 min exclusively contained proteins with the DQ2.5ave-1a epitope and this fraction represented approximately 55.9 g
in 100 g purified protein. While DQ2.5 ave-1b epitope containing
proteins were detected in the retention time range of 38.5–
45.9 min, proteins with DQ2.5-ave-2 epitope were only detected
in the RP peak 11.

Characterization of the Identified Avenin
Types
As the purpose of the avenin feeding trials is to provoke a
T cell response to assess the clinical significance of oats in
CD, it was important for us to confirm the presence of the
previously reported and potentially pathogenic avenin peptides
that encompass T cell epitopes (13). Avenin protein sequences
that were detected in any of the analyzed samples were used
for phylogenetic analysis and epitope mapping. The identity
of the known T cell epitopes and the protein identification
analyses of oat flour and purified avenin samples along with
RP peak analysis were used to annotate the phylogenetic tree
and compare the characteristics of the sequence groups. The
sequences were grouped into major clusters according to the
presence of conserved avenin-specific T cell epitopes (Figure 6,
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TABLE 4 | Protein characterization of the identified RP-HPLC peaks.
Fraction #

No. MS peaks
in HPLC
fraction*

Observed mass
range (m/z)

Most intense
peaks in MALDI
profile

Accession
(Uniprot/
transcript ID)*

Confidence
level

Monoisotopic
mass (signal
peptide removed)

Epitope

1

15

20543–28907

28604
27783

L0L6J0
Asat-prolamin54

99%
99%

30789
23496

DQ2.5-ave-1a
DQ2.5-ave-1a

2

11

21321–28711

27760
21321
28481

L0L6J0
L0L6K1

99%
95%

30789
22031

DQ2.5-ave-1a
DQ2.5-ave-1a

3

9

21327–28652

28467

L0L6J0

99%

30789

DQ2.5-ave-1a

4

6

22038–28675

28498

Asat-prolamin2
Q09072

99%
95%

24703
23539

DQ2.5-ave-1a
DQ2.5-ave-1a

5

5

22049–28704

28486

Asat-Prolamin10
L0L6K1

99%
95%

25189
22031

DQ2.5-ave-1a

6

4

27609–28659

28478

Asat-Prolamin54
L0L6K1
Asat-Prolamin10

99%
99%
99%

23496
22031
25189

DQ2.5-ave-1a
DQ2.5-ave-1a
DQ2.5-ave-1a

7

4

22009–28481

27595

L0L6J0
L0L6K1

99%
99%

30789
22031

DQ2.5-ave-1a
DQ2.5-ave-1a

8

10

21240–28516

24184
22040
27652

Asat-Prolamin10
Q09072

99%
99%

25189
23539

DQ2.5-ave-1a
DQ2.5-ave-1a

9

2

22513–22711

22513

L0L4J7

99%

22481

DQ2.5-ave-1c

10

4

21893–25833

22465

L0L4J7
L0L6J0

99%
99%

22481
30789

DQ2.5-ave-1c
DQ2.5-ave-1a

11

2

21792–22495

22495

L0L4J7
Q09072
I4EP88
I4EP86
L0L6J0

99%
99%
99%
95%
95%

22481
23539
25862
21915
30789

DQ2.5-ave-1c
DQ2.5-ave-1a
DQ2.5-ave-1b
DQ2.5-ave-2
DQ2.5-ave-1a

12

3

22495–22703

22495
22598

L0L4J7
I4EP58

99%
95%

22481
27966

DQ2.5-ave-1c
DQ2.5-ave-1b

13

5

22481–25855

22481

L0L4J7
Asat-Prolamin71
L0L6J0

99%
99%
95%

22481
22752
30789

DQ2.5-ave-1c
DQ2.5-ave-1b
DQ2.5-ave-1a

25850

I4EP58

99%

27966

DQ2.5-ave-1b

25853
23314

Asat-Prolamin71
G8ZCU7
Q09097

99%
99%
99%

22752
21628
Fragment

DQ2.5-ave-1b
DQ2.5-ave-1c

I4EP54
L0L6J0
Asat-Prolamin15

99%
99%
95%

26895
30789
20556

DQ2.5-ave-1b
DQ2.5-ave-1a
DQ2.5-ave-1c

I4EP58
Asat-Prolamin15

99%
99%

27966
20556

DQ2.5-ave-1b
DQ2.5-ave-1c

I4EP57

99%

27948

DQ2.5-ave-1b

14

5

22474–26051

15

11

22642–27149

16

17

18

7

10

8

23317–27187

23317–27328

23735

23729

23294–27363
23294
26370

*Peaks above 10% intensity in MALDI-TOF MS were considered.

responses detectable in the bloodstream (13) in contrast to the
75–80% that would be seen after just four slices of wheat bread
daily (46). To fully assess the clinical safety of oats we argue it will
be important to deliver oats avenin at a “dose” sufficient to trigger
both immune and biologic responses. While immune studies
suggest oats avenin contain immunogenic sequences capable of
stimulating gluten-specific T cells in CD, such a study may help

limit for gluten-free food status. Failure to provide harvesting,
transport and milling facilities dedicated to oats may easily result
in significant inadvertent contamination by wheat grains.
Another challenge with oat feeding studies may arise from
supplying insufficient avenin to provoke a measurable response
in people with CD. With a short-term oral oat challenge of
100 g daily, 8% of patients with CD had pro-inflammatory T cell
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FIGURE 6 | Epitope mapping and phylogenetic analysis of avenin sequences identified from the different protein extracts. Avenin sequences identified from any of the
analyses are shown in the tree and were grouped into five groups (labeled in the inner circle). The sequences that contain epitopes DQ2.5-ave-1a, DQ2.5-ave-1b,
DQ2.5-ave-1c, and DQ2.5-ave-2 are highlighted yellow, red, blue, and dark red, respectively, in the outer ring. Sequences within the same phylogenetic groups
without these epitopes are shown as empty blocks. Those proteins identified using the different protein extraction methods and enzymes are labeled with blue and
teal colored blocks in intermediate rings. Proteins identified from the individual RP HPLC peaks are labeled in gray in the outer ring.

establish a safe threshold dose of oats for consumption in CD by
correlating these findings with clinically important endpoints.
Here, we demonstrate that it is possible to produce 85%
pure oat grain storage protein extracts from oat flour using
repeated 8 kg scale avenin-enriched extractions. The IPA/DTT
method combined with trypsin digestion yields a large number
of gluten proteins from cereal grains such as wheat (31). This
analysis in oats demonstrated that using 50% (v/v) ethanol
was sufficient to identify a majority of the avenin protein
types. The least represented group was that of proteins with
the DQ2.5-ave-1b epitope. This protein type however, was
extracted in higher number using the IPA/DTT solvent. Similarly,

Frontiers in Nutrition | www.frontiersin.org

when reducing agent was added during the purified avenin
resolubilization the protein group was better represented (data
not shown). This indicates that these proteins with 9 cysteine
residues in their sequence might be part of the protein polymer
and therefore less soluble in the absence of reducing agent
(Supplementary Table S2).
The final avenin preparation contains the avenin bands
present in the initial crude 50% (v/v) ethanol extract. Thus, the
majority of avenins are recovered by this process. Ninety six
percent of the protein in the final protein preparation was due
to authentic avenins which were identified by western blotting.
The content of starch, β-glucan, sugars, and fatty acids were low
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sequences with amino acid substitutions or insertions/deletions.
Although the overlapping protein set between the different
extraction protocols and the RP HPLC peak analysis was small,
the avenin sequence analysis confirmed that proteins from the
same avenin sub-types were detected. The background database
used included <200 avenin sequences representing a rather
narrow genetic variability of only a few Avena species and Avena
sativa cultivars. The avenin sequences within the analysis set
share 70–99% sequence identity within the groups and 24–45%
sequence identity between the groups. Only a few avenin proteins
were identified with nearly complete peptide coverage. This also
demonstrates that the avenin sequences present in the cultivar
Wandering are different from those in the public databases.

in the final avenin preparation. Using repeated extractions it is
possible to process 200 kg of oat flour in 9 days to produce ∼1 kg
of food-grade, avenin-enriched freeze-dried powder.
The RP-HPLC peak analysis indicated the presence of ATIs in
the purified sample and this was verified with the comparative
analysis using various extraction methods. The number of ATIs
detected in the 50% (v/v) ethanol purified protein was in the same
range as the avenins. Western blots show the presence of ATI
is <4.2% however the precise amount requires further analysis.
Other prolamin proteins were also detected. The number of
LTPs and kernel structure-related vromindolines was in the
same range as of the avenins. Furthermore, globulins, enzymes,
and metabolic proteins were also present in large number.
Comparison of the IPA/DTT extracted flour sample and the
protein preparate clearly shows the depletion of other protein
types in the protein preparate and the increase of detected
avenin sequences. Using RP-HPLC analysis combined with
the MALDI-TOF MS and LC-MS confirmed the presence of
significant amount of avenins in the sample. RP-HPLC peaks
5, 6, 8 altogether represent about 40% of the measured protein
amount. These peaks were primarily enriched in DQ2.5-ave-1a
containing avenins.
Although CD is not a food allergy, controlling for potential
confounding effects from ATIs or LTPs in the subsequent analysis
of the avenin preparation will be important as these proteins have
been associated with human disease including food allergies and
Baker’s asthma. ATIs have also been implicated in in vitro studies
to contribute to intestinal inflammation via activation of innate
immune pathways (47, 48). Utilizing readouts specific to CD
and gluten such as gluten-specific T cells will ensure assessment
is focussed on biological effects driven by the avenin and not
other components.
The public databases are relatively poor in oat specific
storage protein sequences, therefore wild relatives of Avenae were
also included in the analysis. In total, 185 avenin or aveninlike gliadin sequences were included in the data background.
Due to this poor avenin protein sequence representation a
precise protein identification is rather challenging but our
results clearly indicated that the purified protein is enriched in
avenin and gliadin-like proteins. Importantly, using an expanded
prolamin database that also includes prolamin sequences of other
Poales species, including wheat and barley, we have excluded
the possibility of wheat and barley contamination in the oat
purified protein.
Comparison of the MALDI-TOF and MicroLC-TripleTOF
MS analysis results also revealed that, similar to wheat gliadins,
the avenins show a significant level of genetic variability,
indicating the presence of multiple gene copies with largely
similar protein size and hydrophobicity within the used cultivar.
It also indicates the possible presence of avenin alleles with
slightly different protein mass values in the different Avena sativa
cultivars and Avena species. Some of the protein peaks were
present in multiple adjacent RP-HPLC peaks which might be
due to the resolution limitations of RP-HPLC. Mass differences
<100 Da observed in adjacent RP peaks can be explained by the
presence of post-translational modifications and highly similar
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CONCLUSION
Resolving the issue of oat safety in people with CD will require
feeding studies to assess the clinical and immune effects of
pure oat avenin. The purity of oat avenin can be confirmed by
rigorous proteomic characterization to control for confounding
factors such as contamination or potential cross reactivity. A
requirement for purified oat avenin for feeding studies was
identified as far back as the 1950’s, but until recently, production
of this at a scale and purity suitable for human feeding studies was
not possible. With the method reported here, it is possible for the
first time to generate highly pure avenin suitable for controlled
feedings studies in CD. This will allow the biological effects of
oats avenin to be assessed devoid of the confounding effects from
other oat proteins, sugars or fiber, or non-oat sources of gluten.
We believe this is a crucial advance that will allow this issue to be
definitively assessed and resolved.
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